Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer
出版年份 2015 全文链接
标题
Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer
作者
关键词
-
出版物
Human Vaccines & Immunotherapeutics
Volume 12, Issue 6, Pages 1332-1342
出版商
Informa UK Limited
发表日期
2015-11-21
DOI
10.1080/21645515.2015.1108500
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France
- (2015) Didier Riethmuller et al. BMC PUBLIC HEALTH
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial
- (2015) Dan Apter et al. Clinical and Vaccine Immunology
- Hypothesis: Human papillomavirus vaccination syndrome—small fiber neuropathy and dysautonomia could be its underlying pathogenesis
- (2015) Manuel Martínez-Lavín CLINICAL RHEUMATOLOGY
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- Present status of human papillomavirus vaccine development and implementation
- (2015) Rolando Herrero et al. LANCET ONCOLOGY
- Primary endpoints for future prophylactic human papillomavirus vaccine trials: towards infection and immunobridging
- (2015) Douglas R Lowy et al. LANCET ONCOLOGY
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy
- (2015) Miriam Nakalembe et al. Infectious Agents and Cancer
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014
- (2015) Sarah Reagan-Steiner et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries
- (2015) D Scott LaMontagne et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- HPV Type Attribution in High-Grade Cervical Lesions: Assessing the Potential Benefits of Vaccines in a Population-Based Evaluation in the United States
- (2014) S. Hariri et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Update on Vaccination Clinical Trials for HPV-Related Disease
- (2014) Britt K. Erickson et al. CLINICAL THERAPEUTICS
- Peripheral Sympathetic Nerve Dysfunction in Adolescent Japanese Girls Following Immunization with the Human Papillomavirus Vaccine
- (2014) Tomomi Kinoshita et al. INTERNAL MEDICINE
- Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women
- (2014) B. Baldur-Felskov et al. JNCI-Journal of the National Cancer Institute
- Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
- (2014) Sepehr N Tabrizi et al. LANCET INFECTIOUS DISEASES
- Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2
- (2014) Philip E. Castle et al. OBSTETRICS AND GYNECOLOGY
- No Adverse Signals Observed After Exposure to Human Papillomavirus Type 6/11/16/18 Vaccine During Pregnancy
- (2014) Mary Ann Goss et al. OBSTETRICS AND GYNECOLOGY
- Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
- (2014) Paulo S Naud et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
- (2014) Mark Jit et al. Lancet Global Health
- Impact of Human Papillomavirus Vaccination on Cervical Cytology Screening, Colposcopy, and Treatment
- (2013) A. C. Rodriguez et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Towards the eradication of HPV infection through universal specific vaccination
- (2013) Piergiorgio Crosignani et al. BMC PUBLIC HEALTH
- Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008-2011
- (2013) L. M. Niccolai et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Safety of Human Papillomavirus Vaccines: A Review
- (2013) Kristine K. Macartney et al. DRUG SAFETY
- Review of the current knowledge on the epidemiology, pathogenesis, and prevention of human papillomavirus infection
- (2013) Asia Asiaf et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Postural tachycardia syndrome following human papillomavirus vaccination
- (2013) S. Blitshteyn EUROPEAN JOURNAL OF NEUROLOGY
- Achieving high and equitable coverage of adolescent HPV vaccine in Scotland
- (2013) Katy Sinka et al. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
- (2013) Lauri E. Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
- (2013) L. Grimaldi-Bensouda et al. JOURNAL OF INTERNAL MEDICINE
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
- (2013) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Clinical trials of human papillomavirus vaccines and beyond
- (2013) Matti Lehtinen et al. Nature Reviews Clinical Oncology
- Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England
- (2013) D. Mesher et al. VACCINE
- Infrastructure Requirements for Human Papillomavirus Vaccination and Cervical Cancer Screening in Sub-Saharan Africa
- (2013) Rengaswamy Sankaranarayanan et al. VACCINE
- Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
- (2013) L. Arnheim-Dahlstrom et al. BMJ-British Medical Journal
- Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme
- (2012) Agnes Binagwaho et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Contributions of Recent and Past Sexual Partnerships on Incident Human Papillomavirus Detection: Acquisition and Reactivation in Older Women
- (2012) A. F. Rositch et al. CANCER RESEARCH
- Cervical Cancer Screening, Diagnosis and Treatment Interventions for Racial and Ethnic Minorities: A Systematic Review
- (2012) Susan B. Glick et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
- (2012) S. N. Tabrizi et al. JOURNAL OF INFECTIOUS DISEASES
- A Cohort Effect of the Sexual Revolution May Be Masking an Increase in Human Papillomavirus Detection at Menopause in the United States
- (2012) Patti E. Gravitt et al. JOURNAL OF INFECTIOUS DISEASES
- The Challenge of Follow-Up in a Low-Income Colposcopy Clinic
- (2012) Dana M. Chase et al. Journal of Lower Genital Tract Disease
- Population-Level Impact of the Bivalent, Quadrivalent, and Nonavalent Human Papillomavirus Vaccines: A Model–Based Analysis
- (2012) Nicolas Van de Velde et al. JNCI-Journal of the National Cancer Institute
- Cervical Cancer Trends in the United States: A 35-Year Population-Based Analysis
- (2012) Olusola Adegoke et al. JOURNAL OF WOMENS HEALTH
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Human Papillomavirus Vaccine Introduction – The First Five Years
- (2012) Lauri E. Markowitz et al. VACCINE
- Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study
- (2012) P. Oakeshott et al. BMJ-British Medical Journal
- Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine
- (2011) C. Chao et al. JOURNAL OF INTERNAL MEDICINE
- Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study
- (2011) Julia ML Brotherton et al. LANCET
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
- (2011) Julianne Gee et al. VACCINE
- Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials
- (2010) Dominique Descamps et al. Human vaccines & immunotherapeutics
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Rate of and Risks for Regression of Cervical Intraepithelial Neoplasia 2 in Adolescents and Young Women
- (2010) Anna-Barbara Moscicki et al. OBSTETRICS AND GYNECOLOGY
- Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
- (2009) Barbara A. Slade JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years
- (2009) Cosette M. Wheeler et al. JOURNAL OF INFECTIOUS DISEASES
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years
- (2009) Darron R. Brown et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Infection with Human Papillomavirus and HIV among Young Women in Kampala, Uganda
- (2008) Cecily Banura et al. JOURNAL OF INFECTIOUS DISEASES
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
- Natural History of Human Papillomavirus Infections, Cytologic and Histologic Abnormalities, and Cancer
- (2008) Cosette Marie Wheeler OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
- Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines
- (2008) Thomas Verstraeten et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now